Here we have recorded the effects of metachlorophenylpiperazine (m-CPP) on intracavernous pressure (ICP) in anesthetized rats pretreated with various pharmacological agents in an attempt to determine the mechanism and relevance of the m-CPP induced ICP response to other models of erection. m-CPP elicited consistent and significantly greater increases in ICP (71.5 AE 6.6 mmHg) compared with the mixed 5-HT 2a=2c agonists trifluoromethylphenylpiperazine (3.4 AE 1.3 mmHg) and quipazine (10.9 AE 1.8 mmHg). Blockade of 5-HT 2a receptors with ketanserin failed to unmask any stimulatory effect of quipazine (7.2 AE 1.0 mmHg). m-CPP induced ICP responses (71 AE 7.0 mmHg) were unaffected in the presence of mianserin (63 AE 5 mmHg) and ketanserin (51 AE 12 mmHg). Spiperone significantly reduced the m-CPP induced increase in ICP (8.0 AE 1.0 mmHg). Naloxone, yohimbine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT) failed to elicit increases in ICP on their own. All three drugs significantly reduced the latency to the first m-CPP induced ICP response compared to saline. Yohimbine increased the duration of m-CPP induced ICP responses whereas 8-OHDPAT increased the mean number of m-CPP induced ICP responses compared to saline. The effects of m-CPP on ICP in anesthetized rats may not be mediated by 5-HT 2c receptors and appears to be similar to erection in copula, but not erection elicited by other drugs or penile sheath retraction.
Introduction
Metachlorophenylpiperazine (m-CPP) is a non-selective serotonin (5-HT) agonist that induces erection in conscious rats in a manner that is dependent upon functional supraspinal 5-HT 2c receptors. 1, 2 Other non-selective 5-HT 2a=2c agonists also induce erection in conscious rats when 5-HT 2a receptors are masked by pretreatment with selective 5-HT 2a antagonists. 3, 4 Steers and de Groat 5 found that m-CPP also elicits firing of the cavernous nerve (CN) in anesthetized rats with concomitant increases in intracavernous pressure (ICP). The same authors showed that the effects of m-CPP on the CN and ICP in anesthetized rats were blocked by the nonselective 5-HT antagonist metergoline, enhanced rather than inhibited by spinal transection and abolished by pelvic nerve section. Based on the results of those experiments the authors suggested that the m-CPP induced responses were due to actions at 5-HT 1b receptors within the spinal cord. However, the receptor that mediates the effects of m-CPP on CN and ICP responses in rats remains undetermined.
Previously we demonstrated that the novel 5-HT 2c agonist, RSD992, also elicits erection in conscious rats in a manner dependent upon 5-HT 2c receptors. 6 However, unlike m-CPP RSD992 failed to induce CN and ICP responses in anesthetized rats. 7 Furthermore, the selective 5-HT 1a and 5-HT 1b agonists 8-OHDPAT and CGS12066B enhanced and inhibited, respectively the m-CPP induced CN and ICP responses. 7 Others have demonstrated that 8-OHDPAT and CGS12066B inhibit and have no effect on m-CPP induced erections, respectively, in conscious rats. 3 Therefore contradictory evidence exists for the effects of m-CPP on erection in conscious rats versus its effects on CN and ICP responses in anesthetized rats.
ICP responses resulting from direct nerve stimulation and drug administration are often used as an index of penile erection. 8, 9 Therefore, the following studies were undertaken in an effort to determine if 5-HT 2c receptors are responsible for the effects of m-CPP on ICP responses in anesthetized rats, determine the effects that drugs known to modulate erection and=or sexual behavior in conscious rats have on m-CPP induced CN and ICP responses in anesthetized rats and, discuss the relevance of the m-CPP induced ICP response in relation to other models of erection.
Materials and methods
The National University of Singapore animal use and care committee approved all experimental procedures. Drugs were obtained from Sigma Chemical Co (m-CPP, naloxone, quipazine, yohimbine) or Research Biochemicals Inc. (8-OHDPAT, ketanserin, mianserin, spiperone, trifluoromethylphenylpiperazine) and prepared according to manufacturers instructions.
Male Sprague-Dawley (SD) rats were anesthetized with sodium pentobarbitone (65 mg=kg; i.p.) and prepared for drug administration and blood pressure recording through cannulation of the external jugular vein and internal carotid artery, respectively. The trachea was cannulated for assisted respiration at a volume of 10 ml=kg and a rate of 60 breaths=min.
A median incision was made in the lower pelvic region and the cavernous nerve was isolated from the prostatic pelvic plexus by blunt dissection and suspended on platinum hook electrodes. The pelvic cavity was filled with warm mineral oil to prevent dehydration. Blunt dissection of the ischiocavernous musculature was used to isolate the right penile crus. ICP responses elicited by direct stimulation of the cavernous nerve and drug administration were recorded on computer using polyethylene tubing connected to a 27-gauge needle that was placed into the crus.
Experiments were initiated by stimulation of the cavernous nerve and recording of ICP to determine viability of nerve responses. Fifteen minutes after initial nerve stimulation saline or test drugs were injected and CN and ICP responses were recorded for a further 15 min. After administration of saline or test compounds m-CPP was injected and CN and ICP responses were monitored for an additional 15 min. To end the experiments the CN was again stimulated and ICP recorded to confirm responsiveness to direct stimulation. All drugs were prepared fresh in saline and injected intravenously in a volume of 1.0 ml=kg.
Arterial blood pressure (BP) and ICP were recorded on a MacIntosh 1 computer using MacLab 1 analog to digital conversion and Chart 1 software. The CN was stimulated with square-wave pulses delivered from the MacLab 1 output at 20 Hz, 2.5 V and 1 ms pulse width until a plateau in ICP was observed (30 -60 s) . Changes in ICP were calculated as the difference between the maximal response and the mean ICP over 2 min prior to direct stimulation or drug administration. The number of ICP responses was determined by counting the number of obvious and rapid increases in ICP to pressures equivalent to or above those attained during pre-drug nerve stimulation. Latency to the onset of the first m-CPP induced ICP response was calculated from the start of drug administration to the first rapid rise in ICP. The duration of m-CPP induced ICP responses were calculated as the time from the onset of the first response to the time at which the ICP returned to pre-drug levels.
The first experiment examined the effects of the non-selective 5-HT agonists m-CPP, trifluoromethylphenylpiperazine (TFMPP) and quipazine on CN and ICP responses in anesthetized rats. The second experiment examined the effects of a series of 5-HT 2a=2c antagonists on the m-CPP induced CN and ICP responses in anesthetized rats. The third experiment examined the effects of drugs known to modulate erection and sexual behavior in conscious rats on the m-CPP induced CN and ICP responses in anesthetized rats. Table 1 provides a description of the pharmacological and binding profiles of the test drugs at selected receptors.
Data are expressed as the mean AE standard error of the mean (s.e.m.) for n ¼ 5 animals per test group. Differences between drug and saline treated groups for m-CPP induced ICP variables were determined using ANOVA followed by Dunnett's test for multiple comparisons and P < 0.05 was taken as a significant result in all cases.
Results

Agonist induced intracavernous pressure responses
ICP responses resulting from direct stimulation of the CN (20 Hz, 2.5 V, 1 ms pulse width) were similar 10 Bonhaus et al, 14 Bigoni et al 41 and Paiva et al. 
Antagonism of the m-CPP induced intracavernous pressure response
Pre-drug ICP responses resulting from direct stimulation of the CN were similar amongst treatment groups and ranged from 30 AE 5 mmHg to 38 AE 4 mmHg (P > 0.50). The 5-HT antagonists ketanserin, mianserin and spiperone failed to induce increases in ICP above pre-drug mean ICP values that ranged between 4 AE 4 mmHg and 17 AE 5 mmHg (P > 0.10). ICP responses resulting from direct stimulation of the CN and pre-drug mean ICP responses were not significantly different from those of the saline=m-CPP treatment group from the first experiment. Therefore, the saline=m-CPP group from the first experiment (72 AE 7 mmHg) also served as control for this experiment.
m-CPP induced maximal changes in ICP of 63 AE 5 mmHg and 51 AE 12 mmHg in the presence of mianserin and ketanserin, respectively. However in the presence of spiperone the m-CPP induced ICP (Figure 2 ). Mean ICP values prior to m-CPP administration (4 AE 1 mmHg to 11 AE 2 mmHg) were not significantly different between treatment groups in which m-CPP induced ICP responses. However, this value was significantly higher in the spiperone=m-CPP treatment group as compared to the saline=m-CPP and ketanserin=m-CPP treatment groups (P < 0.05). In the presence of mianserin and ketanserin m-CPP induced 1 AE 0 ICP responses, a value not significantly different from the 1 AE 0 m-CPP induced ICP responses in the presence of saline. However, mianserin and ketanserin did significantly reduce the latency to the first ICP response to 183 AE 12 s and 155 AE 20 s, respectively, from a latency of 285 AE 18 s in saline pre-treated rats. Mean duration of the m-CPP induced ICP responses were 168 AE 14 s and 189 AE 29 s in mianserin and ketanserin pretreated rats, respectively and were not significantly different from a mean duration of 135 AE 24 s in saline pre-treated animals (P > 0.30). All test groups responded to direct stimulation of the cavernous nerve after m-CPP administration with mean increases in ICP ranging from 31 AE 3 mmHg to 48 AE 5 mmHg (P > 0.60).
Modulation of the m-CPP induced intracavernous pressure response
Direct stimulation of the CN resulted in mean increases in ICP ranging from 28 AE 4 to 39 AE 7 mmHg 7 mmHg (P > 0.50) from pre-stimulation mean values ranging between 4 AE 2 mmHg and 13 AE 7 mmHg (P > 0.60). Administration of saline or test drugs (Naloxone, Yohimbine and 8-OHDPAT) failed to directly influence ICP (Panel A in Figures 3 and 4) . Baseline ICP values and maximal changes in ICP after saline or test drug administration were not significantly different between treatment groups (data not shown).
In the presence of naloxone, yohimbine and 8-OHDPAT m-CPP elicited consistent ICP responses above those obtained during direct stimulation of the cavernous nerve in the first and second set of experiments (Panel B in Figures 3 and 4) . m-CPP Table 2) . The duration of ICP responses was prolonged from 149 AE 38 s in saline pre-treated rats to 321 AE 112 s 696 AE 130 s and 492 AE 147 s in rats pre-treated with naloxone, yohimbine and 8-OHDPAT, respectively, but this effect was only significant in the yohimbine pre-treated group (Table 2) .
Discussion
The results of the present study demonstrate that: (1) at equivalent doses m-CPP produces increases in ICP in anesthetized rats whereas its structural analogs TFMPP and quipazine do not; (2) at equivalent doses the 5-HT 2 antagonists spiperone, but not mianserin and ketanserin, antagonize the m-CPP induced increases in ICP; and (3) naloxone, yohimbine and 8-OHDPAT reduce the latency to the onset of the first m-CPP induced ICP response and, tend to increase the number and duration of m-CPP induced ICP responses. Previously we described the erection inducing effects of the novel compound RSD992 and suggested that this response was dependent upon agonist action at 5-HT 2c receptors. 6 m-CPP has also been shown to elicit erection in conscious rats in a 10 the dose used by Steers and de Groat 5 was high enough to eliminate any selectivity in antagonist activity. 11 Therefore, although 5-HT 2c receptors may be important for the m-CPP induced erectile responses mediated through supraspinal mechanisms in conscious rats, other receptors may be responsible for m-CPP induced CN activity and increases in ICP in anesthetized rats.
In an elegant series of experiments Berendsen et al, 3 demonstrated a strong correlation (r ¼ 0.98) between 5-HT 2c =5-HT 2a receptor selectivity ratio, as determined from binding studies, and maximal erectogenic effects in vivo for a group of 1-arylpiperazine 5-HT 2c agonists including m-CPP, TFMPP and quipazine. Furthermore ID 50 doses for antagonism of m-CPP-induced erections in conscious rats were also correlated (r ¼ 7 0.89) with 5-HT 2c receptor selectivity of a range of 5-HT 2 antagonists. 3 Compounds exhibiting selectivity for 5-HT 2a receptors also demonstrate a strong relationship (r > 0.80) between binding affinity at 5-HT 2a sites and doses inhibiting DOI mediated head-twitch response in rats (an in vivo bioassay for 5-HT 2a antagonists). 12 TFMPP, quipazine and m-CPP display similar affinity for 5-HT 2c receptors and, similar potency and efficacy in stimulating IP 3 turnover in rat choroid plexus in vitro (a bioassay for 5-HT 2c agonists). 13 We have conducted an analysis of data presented by Hoyer et al 10 and Bonhaus et al 14 and have determined a strong correlation for the in vivo and in vitro potency of agonists and antagonists at 5-HT 2a =5-HT 2c receptors and binding affinities at native and cloned human and rat 5-HT 2a =5-HT 2c receptors (r ¼ 0.96-0.98; n ¼ 7; t ¼ 7.8 -15.3, t (0.05,5) ¼ 2.571; P < 0.001). Therefore, although complete dose -response curves were not examined in this study, doses were selected based on known in vivo and in vitro potency and selectivity at the various receptor subtypes and, preliminary experiments.
Preliminary dose -response experiments and single equivalent dose experiments both indicated that TFMPP and quipazine failed to initiate increases in ICP over dose ranges known to produce erection in conscious rats (0.3 -3.0 mg=kg), 3 thus supporting the idea that 5-HT 2c receptors may not responsible for the effects of m-CPP on ICP. The possibility that coactivation of 5-HT 2a receptors might mask a 5-HT 2c dependent increase in ICP was excluded by the observed lack of ICP responses during quipazine administration in the presence of 5-HT 2a blockade with ketanserin. The effect of quipazine plus ketanserin on ICP in anesthetized rats in the present study is directly opposite to that produced by the same drug combination on erection in conscious rats. 3, 4 It is also unlikely that 5-HT 2a receptors are responsible for the effects of m-CPP on ICP as TFMPP and m-CPP display similar potency and efficacy as partial agonists at 5-HT 2a receptors in vivo and in vitro. 10, 13 Furthermore, quipazine, a more efficacious but equally potent partial agonist at 5-HT 2a receptors compared to m-CPP and TFMPP, 13, 15 failed to elicit ICP responses on its own.
Results obtained in the present study with three 5-HT 2 antagonists support the idea that 5-HT 2a and 5-HT 2c receptors may not be responsible for the m-CPP induced ICP response. The m-CPP responses in the presence of molar doses of antagonists (70 -100 nmol=kg) known to block 5-HT 2 receptors in vivo and in vitro 11 were similar except for spiperone. Mianserin, ketanserin and spiperone antagonize 5-HT 2a receptor mediated phospholipase C turnover in frontal cortex with K b values of 12, 58 and 6 nM, respectively 16 and block 5-HT 2a mediated responses in vivo over dose ranges (4 -26 mg=kg) 17 -19 encompassing the doses used in the present study. Therefore, if the m-CPP induced ICP responses were mediated by a 5-HT 2a receptor mechanism all of the antagonists might have been expected to diminish, if not abolish, the response at the roughly equimolar doses used in this study. Furthermore, mianserin exhibits similar affinity and potency as an antagonist at 5-HT 2a a and 5-HT 2c receptors whereas ketanserin and spiperone exhibit approximately 100 and 1000-fold less affinity and potency at 5-HT 2c receptors. 16, 20 Therefore mianserin, but not spiperone, might have been expected to block a 5-HT 2c mediated m-CPP effect on ICP. However, in the present study spiperone completely abolished the m-CPP induced ICP response whereas mianserin was without effect. Berendsen et al, 3 have demonstrated that, in contrast to the present study, the m-CPP induced erection in conscious rats ) is blocked by mianserin and ketanserin with ID 50 values of 0.06 and 2.0 mg=kg, respectively, but not by spiperone (0.1 -1.0 mg=kg). Taken together these results suggest that 5-HT 2a and 5-HT 2c receptors may not be responsible for the effects of m-CPP on ICP.
Spiperone is an a-adrenoceptor (ADR) antagonist with a pA 2 for a-adrenoceptor antagonism approximately 100-fold lower than prazosin 21, 22 and, approximately 100-fold lower than its pA 2 for antagonist action at 5-HT 2a receptors. 10 Spiperone exhibits selectivity for the a 1a ADR subtype. 22, 23 Prazosin, a non-selective a 1 -2 antagonist, is often m-CPP induced intracavernous pressure responses ES Hayes and PG Adaikan used to induce erection or enhance erection produced by other agents. 24 However, in anesthetized rats and dogs prazosin tends to reduce ICP elicited by stimulation of the CN but this effect is not clearly dose-dependent and, differs between species. 9 On the other hand, the same authors demonstrated that the selective a 1a ADR antagonist REC 15=2841 failed to inhibit CN mediated ICP responses in rats or dogs at doses 10 -30 times higher than the dose of spiperone used in the present study. Although we are not able to completely rule out an a-ADR antagonist action for the effect of spiperone on m-CPP induced ICP in the present study, it is interesting to note that ketanserin is comparable to spiperone in terms of affinity and potency as an a 1 -ADR antagonist 23, 25 but failed to significantly reduce the m-CPP induced ICP response. Naloxone, yohimbine and 8-OHDPAT have differential effects on erection elicited in different experimental models and were employed here in order to gain some insight into the relevance of the m-CPP induced ICP response to other models of erection. In conscious rats naloxone enhances spontaneous and apomorphine induced erectile activity 26,27 whereas 8-OHDPAT fails to enhance spontaneous erection on its own 2 and, attenuates apomorphine and m-CPP induced erection. 28 Although yohimbine has not been tested for its effects on apomorphine or m-CPP induced erections in conscious rats, the selective a 2 antagonists piperoxan and idazoxan have been shown to lack the ability to attenuate apomorphine-induced erection. 29 8-OHDPAT is a potent inhibitor of 5-HT 2c mediated erections in rats and is in keeping with results regarding physiological antagonism of 5-HT 2c receptor-mediated events by 5-HT 1a agonists. 12 Therefore, the fact that 8-OHDPAT significantly enhanced the m-CPP induced ICP response at doses known to elicit maximal agonist action at 5-HT 1a receptors 12 strongly suggests that the m-CPP induced ICP response in anesthetized rats differs from the m-CPP induced erectile responses in conscious rats.
Naloxone has been shown to either have no effect on, or reduce, the number of erections and latency to ejaculation in tests employing penile sheath retraction to elicit erection. 30, 31 Yohimbine has been shown to inhibit erectile and ejaculation responses elicited by penile sheath retraction at doses similar to the one used in the present study. 32 Similarly, 8-OHDPAT and other selective 5-HT 1a agonists have been shown to completely abolish erectile and ejaculatory responses mediated by penile sheath retraction. 33, 34 The results of the present study clearly demonstrated a positive effect of all the compounds with respect to the number and duration of ICP responses elicited by m-CPP and a reduction in the latency to onset of the first m-CPP induced ICP response. Based on this experimental evidence it is suggested that the m-CPP induced ICP response does not resemble erectile responses elicited by retraction of the penile sheath. In this regard glans erections observed during penile sheath retraction are not attenuated by section of the cavernous nerve 35 whereas m-CPP induced ICP responses in anesthetized rats are abolished by cavernous nerve section, 5 thus suggesting differential mechanisms for these two stimuli as models of erection.
In tests of copulatory performance naloxone has been shown to produce equivocal effects on latency to intromission or ejaculation with no effect at low doses 31, 36 and reduced latency to both variables at higher doses. 37 In contrast, yohimbine reduces both intromission and ejaculation latency 38 and, 8-OHD-PAT strongly reduces intromission and ejaculation latencies and increases the number of ejaculations in copulatory tests. 39, 40 In the present study all three compounds reduced the latency to the first m-CPP induced response and, 8-OHDPAT was particularly effective in this respect. Furthermore, 8-OHDPAT significantly increased the number of ICP responses elicited by m-CPP. The inability of test drugs to elicit ICP responses on their own combined with their ability to enhance m-CPP induced responses suggests that their effects are stimulus dependent. The strong effect observed for 8-OHDPAT in the present study suggests that the m-CPP induced ICP response may resemble erection and ejaculatory patterns observed in copula more closely than erectile responses generated by genital reflex testing and pharmacological stimulation within the CNS.
Conclusion
The results of this study suggest that m-CPP induced increases in intracavernous pressure may not be mediated by 5-HT 2a or 5-HT 2c receptors. Although the receptor responsible for the m-CPP effects on ICP was not identified in the present study it is worthy of further investigation based on the observed interaction with 5-HT 1a receptor stimulation. Naloxone, yohimbine and 8-OHDPAT all reduced the latency to onset of the first m-CPP induced ICP response and tended to increase the number and duration of such responses. Therefore the m-CPP induced ICP response appears to a greater degree of similarity to erection and ejaculation in copula as compared to erection elicited through pharmacological means or genital reflex testing. The ability of 8-OHDPAT to significantly enhance m-CPP induced ICP responses may have implications for the pharmacological inducement of erection and ejaculation. awarded to ES Hayes. LC Lau and B Srilatha are thanked for technical assistance and review of the manuscript.
